Topical Pain Management Therapeutics in Sports Medicine Market: Global Industry Analysis and Forecast 2029

Topical Pain Management Therapeutics in Sports Medicine Market is expected to reach US$ 3.41 Bn. at a CAGR of 5.5 during the forecast period 2029. The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Topical pain management therapeutics are distinctive products which are used to relieve acute musculoskeletal pain or general sprains or strains. Topical Pain Management Therapeutics in Sports Medicine MarketTo know about the Research Methodology :- Request Free Sample Report The treatment comprise several drug classes such as analgesics, anesthetics, and skeletal muscle relaxants. Topical pain relievers are becoming progressively popular in sports category due to their site-specific action, cost-effectiveness, prompt pain relief, and existing in the OTC segment. These are present in the form of gels, sprays, creams, and patches. The scope of the report includes a detailed study of global and regional markets for Topical Pain Management Therapeutics in Sports Medicine with the reasons given for variants in the growth of the industry in certain regions. The growth of the topical pain management therapeutics in sports medicine market is mainly driven by rise in frequency of arthritis and other bone-related circumstances. Additional feature enhancing the topical pain management therapeutics in sports medicine market comprises increase in acceptance of sports medicine products. For instance they cause slighter adverse effects related to oral pain relief, increase in geriatric population across the world, and upsurge in demand for topical pain relief by sports players. Although, Lack of awareness in the direction of pain management in various emerging countries, high cost of medicine, absence of specialty products in emerging countries, etc., are few of the factors restricting the growth of the topical pain management therapeutics in sports medicine market. Additionally, increase in patient choice for pain management devices in treatment of sports injuries is disturbing the growth of topical pain management therapeutics in sports medicine market in many regions. The report on  market covers segments such as Product, Therapeutic Class and Region. The Product segment includes Gels, Creams, Sprays, Patches and Others. Among the product, Gels is accounted for the largest xx% market share in the market. The Therapeutic Class segment is further sub-segmented into Analgesics, Anesthetics, Skeletal Muscle Relaxants and Others. Among the Therapeutic Class, Analgesics is accounted for the largest xx% market share in the Topical Pain Management Therapeutics in Sports Medicine market. Based on regional segment, the global  market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America and Europe are generates the largest revenue for the  market. The United States, United Kingdom and Germany demonstration high implementation rates for topical pain management therapeutics as compared to rest of the world due to increase in number of sports injuries in United States, support of innovative products from US FDA, rise in sports involvement in Europe, established healthcare infrastructure, high frequency of the disease in the region etc. Similarly, Asia Pacific is increase their market due to positive initiatives by governments boosting adolescent’s contribution in sports activities. Developed countries Like Australia and Japan are encouraging for the growth of the market. Increase in sports involvement from the region, government initiatives from countries like China and India etc. will further drive the market in Asia Pacific. Key players operating in the market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.), GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, Johnson & Johnson Services, Inc., and Topical BioMedics, Inc. The companies functioning in the market are concentrating on R&D investments and fund rising activities to drive clinical trials that lead to robust product pipeline. As detection rate and market perception withstand to expand, there are anticipations for market growth during forecast period. Furthermore, innovative product sanctions in the market will further drive the market growth. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the  market.

Scope of the Topical Pain Management Therapeutics in Sports Medicine Market: Inquire before buying

Global Topical Pain Management Therapeutics in Sports Medicine Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.34 Bn.
Forecast Period 2023 to 2029 CAGR: 5.5% Market Size in 2029: US $ 3.41 Bn.
Segments Covered: by Product Gels Creams Sprays Patches Others
by Therapeutic Class Analgesics Anesthetics Skeletal Muscle Relaxants Others

Topical Pain Management Therapeutics in Sports Medicine Market, By Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Topical Pain Management Therapeutics in Sports Medicine Market Key Players are:

1. Pfizer, Inc. 2. Teva Pharmaceutical Industries Ltd. 3. Hisamitsu Pharmaceutical Co., Inc. 4. Mayne Pharma Group Ltd. 5. Sanofi (Chattem, Inc.) 6. GlaxoSmithKline plc. 7. Endo Pharmaceuticals Inc. 8. Beiersdorf AG 9. Johnson & Johnson Services, Inc. 10. Topical BioMedics, Inc 11. Reckitt Benckiser Group Plc 12. Sun Pharmaceutical Industry Ltd 13. Nestl S A 14. Advacare Pharma 15. Grunenthal Gmbh

Frequently Asked questions

1. What is the market size of the Global  Market in 2022? Ans. The market size Global  Market in 2022 was US$ 2.34 Billion. 2. What are the different segments of the Global Market? Ans. The Global  Market  is divided into Product and Therapeutic Class. 3. What is the study period of this market? Ans. The Global Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Market share? Ans. The Asia Pacific dominates the market share in the  market. 5. What  is the Forecast Period of Global  Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
Topical Pain Management Therapeutics in Sports Medicine Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Topical Pain Management Therapeutics in Sports Medicine Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast 6.1. Global Topical Pain Management Therapeutics in Sports Medicine Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 7.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, By Product 7.5. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis, By Product 7.6. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis, By Product 8. Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast, By Therapeutic Class 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 8.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, By Therapeutic Class 8.5. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis, By Therapeutic Class 8.6. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis, By Therapeutic Class 9. Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Region 9.1. Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Region 9.2. Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, by Region 9.3. Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis, by Region 10. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis 10.1. Key Findings 10.2. North America Topical Pain Management Therapeutics in Sports Medicine Market Overview 10.3. North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 10.4. North America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 10.4.1. Gels 10.4.2. Creams 10.4.3. Sprays 10.4.4. Patches 10.4.5. Others 10.5. North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 10.6. North America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 10.6.1. Analgesics 10.6.2. Anesthetics 10.6.3. Skeletal Muscle Relaxants 10.6.4. Others 10.7. North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Country 10.8. North America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Country 10.10. U.S. Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 10.10.1. Gels 10.10.2. Creams 10.10.3. Sprays 10.10.4. Patches 10.10.5. Others 10.11. U.S. Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 10.11.1. Analgesics 10.11.2. Anesthetics 10.11.3. Skeletal Muscle Relaxants 10.11.4. Others 10.12. Canada Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 10.12.1. Gels 10.12.2. Creams 10.12.3. Sprays 10.12.4. Patches 10.12.5. Others 10.13. Canada Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 10.13.1. Analgesics 10.13.2. Anesthetics 10.13.3. Skeletal Muscle Relaxants 10.13.4. Others 10.14. North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Therapeutic Class 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis 11.1. Key Findings 11.2. Europe Topical Pain Management Therapeutics in Sports Medicine Market Overview 11.3. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 11.4. Europe Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.4.1. Gels 11.4.2. Creams 11.4.3. Sprays 11.4.4. Patches 11.4.5. Others 11.5. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 11.6. Europe Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.6.1. Analgesics 11.6.2. Anesthetics 11.6.3. Skeletal Muscle Relaxants 11.6.4. Others 11.7. Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Country 11.8. Europe Topical Pain Management Therapeutics in Sports Medicine Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Country 11.10. Germany Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.10.1. Gels 11.10.2. Creams 11.10.3. Sprays 11.10.4. Patches 11.10.5. Others 11.11. Germany Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.11.1. Analgesics 11.11.2. Anesthetics 11.11.3. Skeletal Muscle Relaxants 11.11.4. Others 11.12. U.K. Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.12.1. Gels 11.12.2. Creams 11.12.3. Sprays 11.12.4. Patches 11.12.5. Others 11.13. U.K. Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.13.1. Analgesics 11.13.2. Anesthetics 11.13.3. Skeletal Muscle Relaxants 11.13.4. Others 11.14. France Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.14.1. Gels 11.14.2. Creams 11.14.3. Sprays 11.14.4. Patches 11.14.5. Others 11.15. France Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.15.1. Analgesics 11.15.2. Anesthetics 11.15.3. Skeletal Muscle Relaxants 11.15.4. Others 11.16. Italy Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.16.1. Gels 11.16.2. Creams 11.16.3. Sprays 11.16.4. Patches 11.16.5. Others 11.17. Italy Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.17.1. Analgesics 11.17.2. Anesthetics 11.17.3. Skeletal Muscle Relaxants 11.17.4. Others 11.18. Spain Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.18.1. Gels 11.18.2. Creams 11.18.3. Sprays 11.18.4. Patches 11.18.5. Others 11.19. Spain Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.19.1. Analgesics 11.19.2. Anesthetics 11.19.3. Skeletal Muscle Relaxants 11.19.4. Others 11.20. Rest of Europe Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 11.20.1. Gels 11.20.2. Creams 11.20.3. Sprays 11.20.4. Patches 11.20.5. Others 11.21. Rest of Europe Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 11.21.1. Analgesics 11.21.2. Anesthetics 11.21.3. Skeletal Muscle Relaxants 11.21.4. Others 11.22. Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 11.22.1. By Product 11.22.2. By Therapeutic Class 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis 12.1. Key Findings 12.2. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Overview 12.3. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 12.4. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.4.1. Gels 12.4.2. Creams 12.4.3. Sprays 12.4.4. Patches 12.4.5. Others 12.5. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 12.6. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.6.1. Analgesics 12.6.2. Anesthetics 12.6.3. Skeletal Muscle Relaxants 12.6.4. Others 12.7. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Country 12.8. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Country 12.10. China Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.10.1. Gels 12.10.2. Creams 12.10.3. Sprays 12.10.4. Patches 12.10.5. Others 12.11. China Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.11.1. Analgesics 12.11.2. Anesthetics 12.11.3. Skeletal Muscle Relaxants 12.11.4. Others 12.12. India Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.12.1. Gels 12.12.2. Creams 12.12.3. Sprays 12.12.4. Patches 12.12.5. Others 12.13. India Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.13.1. Analgesics 12.13.2. Anesthetics 12.13.3. Skeletal Muscle Relaxants 12.13.4. Others 12.14. Japan Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.14.1. Gels 12.14.2. Creams 12.14.3. Sprays 12.14.4. Patches 12.14.5. Others 12.15. Japan Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.15.1. Analgesics 12.15.2. Anesthetics 12.15.3. Skeletal Muscle Relaxants 12.15.4. Others 12.16. ASEAN Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.16.1. Gels 12.16.2. Creams 12.16.3. Sprays 12.16.4. Patches 12.16.5. Others 12.17. ASEAN Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.17.1. Analgesics 12.17.2. Anesthetics 12.17.3. Skeletal Muscle Relaxants 12.17.4. Others 12.18. Rest of Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 12.18.1. Gels 12.18.2. Creams 12.18.3. Sprays 12.18.4. Patches 12.18.5. Others 12.19. Rest of Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 12.19.1. Analgesics 12.19.2. Anesthetics 12.19.3. Skeletal Muscle Relaxants 12.19.4. Others 12.20. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Therapeutic Class 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Overview 13.3. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 13.4. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 13.4.1. Gels 13.4.2. Creams 13.4.3. Sprays 13.4.4. Patches 13.4.5. Others 13.5. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 13.6. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 13.6.1. Analgesics 13.6.2. Anesthetics 13.6.3. Skeletal Muscle Relaxants 13.6.4. Others 13.7. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Country 13.8. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Country 13.10. GCC Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 13.10.1. Gels 13.10.2. Creams 13.10.3. Sprays 13.10.4. Patches 13.10.5. Others 13.11. GCC Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 13.11.1. Analgesics 13.11.2. Anesthetics 13.11.3. Skeletal Muscle Relaxants 13.11.4. Others 13.12. South Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 13.12.1. Analgesics 13.12.2. Anesthetics 13.12.3. Skeletal Muscle Relaxants 13.12.4. Others 13.13. Rest of Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 13.13.1. Gels 13.13.2. Creams 13.13.3. Sprays 13.13.4. Patches 13.13.5. Others 13.14. Rest of Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 13.14.1. Analgesics 13.14.2. Anesthetics 13.14.3. Skeletal Muscle Relaxants 13.14.4. Others 13.15. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 13.15.1. By Product 13.15.2. By Therapeutic Class 13.16. PEST Analysis 13.17. Key Trends 13.18. Key Developments 14. South America Topical Pain Management Therapeutics in Sports Medicine Market Analysis 14.1. Key Findings 14.2. South America Topical Pain Management Therapeutics in Sports Medicine Market Overview 14.3. South America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Product 14.4. South America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 14.4.1. Gels 14.4.2. Creams 14.4.3. Sprays 14.4.4. Patches 14.4.5. Others 14.5. South America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, By Therapeutic Class 14.6. South America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 14.6.1. Analgesics 14.6.2. Anesthetics 14.6.3. Skeletal Muscle Relaxants 14.6.4. Others 14.7. South America Topical Pain Management Therapeutics in Sports Medicine Market Value Share Analysis, by Country 14.8. South America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Topical Pain Management Therapeutics in Sports Medicine Market Analysis, by Country 14.10. Brazil Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 14.10.1. Gels 14.10.2. Creams 14.10.3. Sprays 14.10.4. Patches 14.10.5. Others 14.11. Brazil Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 14.11.1. Analgesics 14.11.2. Anesthetics 14.11.3. Skeletal Muscle Relaxants 14.11.4. Others 14.12. Mexico Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 14.12.1. Gels 14.12.2. Creams 14.12.3. Sprays 14.12.4. Patches 14.12.5. Others 14.13. Mexico Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 14.13.1. Analgesics 14.13.2. Anesthetics 14.13.3. Skeletal Muscle Relaxants 14.13.4. Others 14.14. Rest of South America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Product 14.14.1. Gels 14.14.2. Creams 14.14.3. Sprays 14.14.4. Patches 14.14.5. Others 14.15. Rest of South America Topical Pain Management Therapeutics in Sports Medicine Market Forecast, By Therapeutic Class 14.15.1. Analgesics 14.15.2. Anesthetics 14.15.3. Skeletal Muscle Relaxants 14.15.4. Others 14.16. South America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness Analysis 14.16.1. By Product 14.16.2. By Therapeutic Class 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Therapeutic Classs and R&D investment 15.2.2. New Treatment Center Launches and Treatment Center Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Therapeutic Classs 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Pfizer, Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Treatment Center Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Teva Pharmaceutical Industries Ltd. 15.3.3. Hisamitsu Pharmaceutical Co., Inc. 15.3.4. Mayne Pharma Group Ltd. 15.3.5. Sanofi (Chattem, Inc.) 15.3.6. GlaxoSmithKline plc. 15.3.7. Endo Pharmaceuticals Inc. 15.3.8. Beiersdorf AG 15.3.9. Johnson & Johnson Services, Inc. 15.3.10. Topical BioMedics, Inc. 15.3.11. Reckitt Benckiser Group Plc 15.3.12. Sun Pharmaceutical Industry Ltd 15.3.13. Nestl S A 15.3.14. Advacare Pharma 15.3.15. Grunenthal Gmbh 16. Primary Key Insights
  • INQUIRE BEFORE BUYING